ketoconazole and navitoclax

ketoconazole has been researched along with navitoclax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Graham, A; Holen, K; Patnaik, A; Pradhan, R; Salem, AH; Xiong, H; Yang, J	1

Other Studies

1 other study(ies) available for ketoconazole and navitoclax

Article	Year
Effect of co-administration of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics, safety and tolerability of navitoclax, a first-in-class oral Bcl-2 family inhibitor, in cancer patients. Anticancer research, 2014, Volume: 34, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Antineoplastic Agents; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Risk Factors; Sulfonamides; Treatment Outcome	2014

Article

Year

Effect of co-administration of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics, safety and tolerability of navitoclax, a first-in-class oral Bcl-2 family inhibitor, in cancer patients.

Anticancer research, 2014, Volume: 34, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Antineoplastic Agents; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Risk Factors; Sulfonamides; Treatment Outcome

2014